Pharmaceutical Strategy Consulting
Tailored solutions for successful pharmaceutical development and market access in China and across the Asia Pacific region.
China and the Asia Pacific region offer vast opportunities for pharmaceutical companies, but navigating these markets requires deep regulatory insight, clinical development expertise, and strategic foresight. Cisema supports international life sciences organizations with customized consulting services that span the full product lifecycle, from early-stage development to successful commercialization.
With over 20 years of regional expertise, we help ensure that your medical products meet evolving regulatory requirements, accelerate drug development timelines and achieve market access across diverse APAC jurisdictions. Our integrated approach combines regulatory strategy, clinical development support, and operational execution - tailored to the needs of start-ups, mid-size companies, and global pharmaceutical leaders.



We align regulatory compliance with business strategy, helping clients build capabilities and seize emerging growth opportunities. Whether you're preparing for clinical trials, navigating NMPA submissions, or expanding across ASEAN, South Korea, Japan, or Australia, our bilingual teams across Europe and Asia deliver accurate, timely, and compliant submissions.
Cisema’s consulting services are designed to support biotech innovators, life sciences companies, academia and clinical research organizations with strategic planning, data analytics, and regulatory intelligence. We work across the value chain - from clinical development to post-market lifecycle management - to define stakeholder value, optimize resource allocation, and improve patient outcomes.
Our China & APAC Pharmaceutical Consulting Services:
Whether you’re entering China or an APAC market for the first time, scaling operations, or seeking support during early-stage development, Cisema provides strategic guidance and regional regulatory expertise to help you navigate every phase of the pharmaceutical product lifecycle. With over 20 years of experience, we empower life sciences companies to make informed decisions and capture growth opportunities across Asia Pacific’s dynamic healthcare landscape.
Drug Development Strategy & Planning
We design development strategies that align clinical, regulatory, and commercial milestones with the diverse market conditions across Asia Pacific. Our roadmaps streamline submissions, eliminate barriers, and optimize resource allocation from concept to launch.
Regulatory & Clinical GAP Analysis
Our experts assess your documentation for alignment with local regulatory and clinical requirements. We identify gaps and provide actionable recommendations to support both innovative and generic drug submissions, reducing risk and improving approval efficiency.
Expedited Approval Pathways
We help you leverage fast-track designations, priority reviews, and conditional approvals available in China and other Asia Pacific markets. Our team guides you through eligibility assessments and application preparation to accelerate time to market.
Regulatory Authority Engagement & Submission Preparation
Acting as your liaison with national health authorities, we manage regulatory interactions, prepare submission-ready technical documentation, and ensure alignment with local standards for a smooth review process
Clinical Trial Strategy & Local Study Design
We evaluate the acceptability of foreign clinical data and determine the need for local trials. Our experts support protocol design, site selection, and operational management to ensure compliant and efficient clinical development.
Regulatory, Scientific & Medical Writing
We prepare high-quality documentation, including CTD modules, clinical summaries, and safety narratives, tailored to local regulatory expectations. Clear, well-structured submissions improve engagement with authorities and facilitate faster approvals.
Market Access & Commercial Strategy
Post-approval, we help position your product for commercial success through:
Why Work with Cisema?
Local expertise with global reach
Our bilingual teams bridge international quality standards with local regulations
Proven track record
Over 20 years supporting market approvals and compliance in China and Asia Pacific
End-to-end solutions
From system setup to post-market surveillance, we ensure quality management and regulatory compliance throughout the product lifecycle
Industry breadth
Cross-sector expertise in life sciences, food, veterinary, consumer and industrial goods

Frequently Asked Questions
Common hurdles include data localization, fragmented and frequent regulatory updates, and strict post-market obligations. We help you address these early with clear strategies that reduce approval timelines and costs.
Early communication with national authorities clarifies requirements and minimizes risk. Our experts support pre-submission meetings, technical reviews, and strategic planning to set your submission up for success.
We assess eligibility and manage the entire process, from dossier preparation to interactions with regulators, to maximize your product’s chances of accelerated review.
Trials must meet local regulatory, ethical, and cultural expectations. We help design trials that comply with each country’s standards, leverage foreign data where applicable, and avoid delays.
We assist with pharmacovigilance, lifecycle management, and updates to maintain compliance with evolving regulations and market requirements.
Request a Proposal from Our Pharma Team
Let Cisema help turn your plans into reality.
Explore Related Services
Pharmaceutical Regulatory Affairs
Navigate regulatory complexity across China and Asia Pacific with confidence. Our regulatory affairs consulting experts support life sciences companies with strategic planning, compliant submissions, and local representation to accelerate approvals and ensure market readiness.
Health Economics & Market Access
Accelerate access across China and Asia Pacific with confidence. Our market access consulting experts help life sciences companies optimize patient access, navigate pricing and reimbursement challenges, and enable commercial success through real world evidence, health economics, and tailored access strategies.
Pharmacovigilance
Ensure drug safety and regulatory compliance across China and Asia Pacific with confidence. Our pharmacovigilance consulting experts support life sciences companies in managing risks, meeting evolving safety requirements, and maintaining market authorization through end-to-end PV solutions tailored to local regulations.
Quality Management & Compliance
Ensure regulatory excellence across China and Asia Pacific with confidence. Our quality management and compliance experts help life sciences companies strengthen GxP systems, streamline audits, and maintain inspection readiness to safeguard market access and operational performance.







